Derivative Suit Filed In Wake Of Record Pfizer Payout

Law360, New York (September 11, 2009, 4:03 PM EDT) -- The entire board of directors at Pfizer Inc. and certain executives have been smacked with a shareholder derivative lawsuit alleging they harmed the company by promoting prescription drugs for unapproved, off-label uses.

The suit was filed Sept. 10 in the U.S. District Court for the Southern District of New York, just eight days after Pfizer agreed to pay a record $2.3 billion in civil and criminal fines.

It accuses 17 individual defendants, including CEO Jeffrey B. Kindler and CFO Frank D'Amelio, of breach of fiduciary duties...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In re Pfizer Inc. Shareholder Derivative Litigation


Case Number

1:09-cv-07822

Court

New York Southern

Nature of Suit

Other Statutory Actions

Judge

Jed S. Rakoff

Date Filed

September 10, 2009

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.